Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study. Tian J, Zhang Q, Peng M, Guo L, et al. Respir Res 2025;26:173.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tian J, Zhang Q, Peng M, Guo L, et al. Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study. Respir Res 2025;26:173.
PMID: 40325477